Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Sun Pharmaceuticals Plans Princeton, New Jersey, Headquarters

03/18/2025
Multinational pharmaceutical company Sun Pharmaceutical Industries plans to establish operations in Princeton, New Jersey. The project is expected to create 220 jobs.

The company’s new 100,000-square-foot U.S. headquarters will be located at 750 College Road East.

“With our long history as a valued corporate member of the state of New Jersey and the Princeton community, Sun Pharma is proud to participate in the Emerge Program,” said Abhay Gandhi, CEO Sun Pharma North America. “As we continue to bolster investments in our innovative medicines, generics and consumer medicines businesses, we look forward to seeing the positive impact our growth will have for New Jersey, the Princeton community and the patients we support.”

To support the project the New Jersey Economic Development Authority Board approved tax credits under the Emerge Program which will award $748,000 in tax credits yearly for seven years, totaling $5,236,000. As part of the program’s requirements, Sun Pharma will also remain in New Jersey for a minimum of 11 years.

“Governor Murphy’s commitment to supporting New Jersey’s life sciences industry is keeping the Garden State competitive, helping grow our economy and create new, good-paying jobs,” noted NJEDA Chief Executive Officer Tim Sullivan. “From Genmab to Sun Pharma, the Emerge Program is having a major impact on cutting-edge companies choosing to do business in New Jersey. Along with our talent pool and prime location, New Jersey is poised to welcome more innovators and entrepreneurs to our state.”

Sun Pharma engages in pharmaceutical and medicine manufacturing and is the fourth largest specialty generic pharmaceutical company in the world.

Exclusive Research